Impact of four rounds of mass drug administration with dihydroartemisinin-piperaquine implemented in Southern Province, Zambia

American Journal of Tropical Medicine and Hygiene

Volumn 103, Issue 2, 2020, Pages 7-18

  Eisele, Thomas P ^a   Bennett, Adam ^b   Silumbe, Kafula ^c   Finn, Timothy P ^a   Porter, Travis R ^a   Chalwe, Victor ^d   Hamainza, Busiku ^e   Moonga, Hawela ^e   Kooma, Emmanuel ^e   Kawesha, Elizabeth Chizema ^e   Kamuliwo, Mulakwa ^f   Yukich, Joshua O ^a   Keating, Joseph ^a   Schneider, Kammerle ^g   Conner, Ruben O ^g   Earle, Duncan ^c   Slutsker, Laurence ^g   Steketee, Richard W ^g   Miller, John M ^c  

^a TULANE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Malaria Control and Evaluation Partnership in Africa (MACEPA)   (Zambia)

^d UNIVERSITY TEACHING HOSPITAL   (Zambia)

^e MINISTRY OF HEALTH   (Zambia)

^f Zambia Ministry of Health   (Zambia)

^g PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ARTICLE; CHILD; CLINICAL EFFECTIVENESS; COMMUNITY CARE; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MASS DRUG ADMINISTRATION; MEDICATION COMPLIANCE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; TREATMENT OUTCOME; TREND STUDY; ZAMBIA; COMBINATION DRUG THERAPY; DISEASE ERADICATION; INCIDENCE; MALARIA FALCIPARUM; PROCEDURES; PROGRAM EVALUATION;

ANTIMALARIALS; ARTEMISININS; DISEASE ERADICATION; DRUG THERAPY, COMBINATION; HUMANS; INCIDENCE; MALARIA, FALCIPARUM; MASS DRUG ADMINISTRATION; PROGRAM EVALUATION; QUINOLINES; ZAMBIA;

EID: 85089301548     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.19-0659     Document Type: Article

References (33)

1. Zambia Ministry of Health, 2015. Zambia National Malaria Indicator Survey 2015. Lusaka, Zambia: Zambia Ministry of Health.
2. Zambia Ministry of Health, 2017. NMEC, ed. National Malaria Elimination Strategic Plan 2017-2021: A Strategy to Move from Accelerated Burden Reduction to Malaria Elimination in Zambia (Brief). Lusaka, Zambia: Zambia Ministry of Health.
3. Eisele TP et al., 2016. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in Southern Province Zambia: a cluster-randomized controlled trial. J Infect Dis 214: 1831-1839.
4. Eisele TP et al., 2015. Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial. Trials 16: 347.
5. Larsen DA, Bennett A, Silumbe K, Hamainza B, Yukich JO, Keating J, Littrell M, Miller JM, Steketee RW, Eisele TP, 2015. Population-wide malaria testing and treatment with rapid diagnostic tests and artemether-lumefantrine in southern Zambia: a community randomized step-wedge control trial design. Am J Trop Med Hyg 92: 913-921.
6. Wei LJ, Lachin JM, 1988. Properties of the urn randomization in clinical trials. Control Clin Trials 9: 345-364.
7. Zambia Ministry of Health, 2014. Guidelines on Diagnosis and Treatment of Malaria in Zambia, 4th Edition. Lusaka, Zambia: Zambia Ministry of Health.
8. Silumbe K et al., 2020. Assessment of the acceptability of testing and treatment during mass drug administration trial for malaria in Zambia using mixed methods. Am J Trop Med Hyg 103 (Suppl 2): 28-36.
9. Finn TP et al., 2020. Treatment coverage estimation for mass drug administration for malaria with dihydroartemisinin-piperaquine in Southern Province, Zambia. Am J Trop Med Hyg 103 (Suppl 2): 19-27.
10. Finn TP et al., 2020. Adherence to mass drug administration with dihydroartemisinin-piperaquine and Plasmodium falciparum clearance in Southern Province, Zambia. Am J Trop Med Hyg 103 (Suppl 2): 37-45.
11. Hayes RJ, Bennett S, 1999. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol 28: 319-326.
12. Bennett A et al., 2020. A longitudinal cohort to monitor malaria infection incidence during mass drug administration in Southern Province, Zambia. Am J Trop Med Hyg 103 (Suppl 2): 54-65.
13. Chalwe V, Silumbe K, Finn TP, Hamainza B, Porter T, Kamuliwo M, Kawesha EC, Miller JM, Steketee RW, Eisele TP, 2017. Adverse event reporting from malaria mass drug administration rounds conducted in southern Zambia. Am J Trop Med Hyg 95: 487.
14. von Seidlein L et al., 2019. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in southeast Asia: a cluster randomised trial. PLoS Med 16: e1002745.
15. Chanda E, Chanda J, Kandyata A, Phiri FN, Muzia L, Haque U, Baboo KS, 2013. Efficacy of ACTELLIC 300 CS, pirimiphos methyl, for indoor residual spraying in areas of high vector resistance to pyrethroids and carbamates in Zambia. J Med Entomol 50: 1275-1281.
16. Choi KS et al., 2014. Insecticide resistance and role in malaria transmission of Anopheles funestus populations from Zambia and Zimbabwe. Parasit Vectors 7: 464.
17. Bennett A et al., 2017. Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003-2015: a modelling study using data from national surveys. Lancet Glob Health 5: e418-e427.
18. Lengeler C, 2004. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev 2004: CD000363.
19. Pluess B, Tanser FC, Lengeler C, Sharp BL, 2010. Indoor residual spraying for preventing malaria. Cochrane Database Syst Rev 4: CD006657.
20. Gimnig JE et al., 2003. Impact of permethrin-treated bed nets on entomologic indices in an area of intense year-round malaria transmission. Am J Trop Med Hyg 68: 16-22.
21. Bousema JT et al., 2006. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis 193: 1151-1159.
22. Drakeley CJ, Jawara M, Targett GA, Walraven G, Obisike U, Coleman R, Pinder M, Sutherland CJ, 2004. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop Med Int Health 9: 53-61.
23. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, Alexander N, Coleman R, Pinder M, Walraven G, Targett GA, 2005. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med 2: e92.
24. Griffin JT, Ferguson NM, Ghani AC, 2014. Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa. Nat Commun 5: 3136.
25. Okell LC et al., 2014. Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis. Nat Commun 5: 5606.
26. Yukich J, Briët O, Bretscher MT, Bennett A, Lemma S, Berhane Y, 2012. Estimating Plasmodium falciparum transmission rates in low-endemic settings using a combination of community prevalence and health facility data. PLoS One 7: e42861.
27. Elliott RC, Smith DL, Echodu D, 2018. Medical and entomological malarial interventions, a comparison and synergy of two control measures using a Ross/MacDonald model variant and open-malaria simulation. Math Biosci 300: 187-200.
28. Hawley WA et al., 2003. Community-wide effects of permethrin-treated bed nets on child mortality and malaria morbidity in western Kenya. Am J Trop Med Hyg 68: 121-127.
29. Parker DM et al., 2019. Potential herd protection against Plasmodium falciparum infections conferred by mass antimalarial drug administrations. Elife 8: e41023.
30. Brady OJ et al., 2017. Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study. Lancet Glob Health 5: e680-e687.
31. Eisele TP et al., 2020. Impact of four rounds of mass drug administration with dihydroartemisinin-piperaquine implemented in Southern Province, Zambia. Am J Trop Med Hyg 103 (Suppl 2): 7-18.
32. Porter T et al., 2017. Assessing associations between recent travel and malaria parasite prevalence during a mass drug administration campaign in southern Zambia. Am J Trop Med Hyg 95: 282.
33. Keating J, Miller J, Bennett A, Moonga H, Eisele T, 2009. Plasmodium falciparum parasite infection prevalence from a household survey in Zambia using microscopy and a rapid diagnostic test: implications for monitoring and evaluation. Acta Trop 112: 277-282.